Most insurance accepted. Click for details
The Alta Mira residential substance use disorder treatment programs were designed by renowned specialists who are among the best in their respective fields.
A mental health condition, Post-Traumatic Stress Disorder (PTSD) develops after exposure to a traumatic event. It causes persistent symptoms that interfere with daily functioning, such as:
PTSD is a biological and psychological response to overwhelming stress. It is not a sign of weakness. In most people, evidence-based treatment significantly reduces symptoms. Long-term outcomes and quality of life are improved by early, appropriate care.
Any event that threatens life or safety, including combat, sexual assault, accidents, natural disasters, or childhood abuse, can lead to PTSD. The American Psychiatric Association classifies PTSD symptoms into four categories [1]:
About 70% of adults in the U.S. experience at least one traumatic event during their lifetime. Of those, approximately 20% develop PTSD.
PTSD affects about 8 million Americans in any given year. Women are diagnosed at twice the rate of men, in part because of higher rates of interpersonal trauma [2].
Several therapeutic approaches have strong research support and are recommended by leading psychiatric and psychological organizations. The most effective options for PTSD are trauma-focused.
All three are recognized by the American Psychological Association as having strong or moderate evidence for PTSD. Most people see meaningful symptom reduction within 8 to 16 sessions.
Medication does not cure PTSD, but it can reduce symptoms enough to make therapy more effective. The table below summarizes the two FDA-approved medications for PTSD and one commonly used off-label option.
| Medication | Class | Primary Use |
| Sertraline (Zoloft) | SSRI (FDA-approved) | Reduces core PTSD symptoms |
| Paroxetine (Paxil) | SSRI (FDA-approved) | Reduces core PTSD symptoms |
| Prazosin | Alpha-blocker (off-label) | Reduces trauma-related nightmares |
A prescribing physician or psychiatrist determines whether medication is appropriate based on symptom severity, other health conditions, and personal preference [4].
Research into PTSD treatment continues to expand. Several emerging approaches are beginning to gain clinical acceptance:
Many people with PTSD do not receive treatment because of stigma, fear of revisiting trauma, or limited access to care. Avoidance is a core symptom of PTSD itself, which makes seeking help harder. Telehealth has significantly expanded access to trauma-focused therapy, particularly in rural and underserved areas [7].
Trauma-focused care does not require you to recount every detail of what happened. A skilled clinician paces the process carefully so that treatment does not feel re-traumatizing. You are always in control of what you share and when.

A typical PTSD treatment plan follows a structured path.
For those seeking this level of specialized, integrated care in the San Francisco Bay area, Alta Mira Recovery Programs is a high-end, top-tier residential addiction center specializing in the treatment of substance use disorders and complex co-occurring mental health issues.
Our exceptional team of highly credentialed addiction treatment professionals provides the most sophisticated level of clinical care and diagnostic services, reflecting our appreciation for your unique qualities.
Contact our compassionate admissions team to learn more.
| [1] | American Psychiatric Association. (2022). What is PTSD? Psychiatry.org. |
| [2] | National Institute of Mental Health. (2023). Post-traumatic stress disorder (PTSD). NIMH. |
| [3] | American Psychological Association. (2017). Eye movement desensitization and reprocessing (EMDR) therapy. APA Clinical Practice Guideline. |
| [4] | Reisman, M. (2016). PTSD treatment for veterans: What’s working, what’s new, and what’s next. P&T: A Peer-Reviewed Journal for Formulary Management, 41(10), 623-634. |
| [5] | Mitchell, J. M., Bogenschutz, M., Lilienstein, A., Harrison, C., Kleiman, S., Parker-Guilbert, K., & Doblin, R. (2021). MDMA-assisted therapy for severe PTSD: A randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine, 27(6), 1025-1033. |
| [6] | van der Kolk, B. A., Stone, L., West, J., Rhodes, A., Emerson, D., Suvak, M., & Spinazzola, J. (2014). Yoga as an adjunctive treatment for posttraumatic stress disorder: A randomized controlled trial. The American Journal of Psychiatry, 171(6), 541-548. |
| [7] | Morland, L. A., Mackintosh, M. A., Glassman, L. H., Wells, S. Y., Thorp, S. R., Rauch, S. A., & Frueh, B. C. (2020). Home-based delivery of variable length prolonged exposure therapy: A comparison of clinical efficacy between service modalities. Depression and Anxiety, 37(4), 346-355. |